fucoxanthin: Clinical Trials

3 trials of fucoxanthin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 2 Phase 2, 1 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Not applicable1Unknown 1

Follow fucoxanthin: new trials by email Literature Review of fucoxanthin trials Research Report on fucoxanthin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of the Combination Therapy of Fucoidan / Fucoxanthin / L-carnitine in Patients With Diabetic Nephropathy.
Oligo-fucoidan, Fucoxanthin, L-carnitine Formula, Zinc yeast (FFL) - Diabetic Kidney Disease (DKD)
Phase 2CompletedTaipei Medical University WanFang Hospital632024-11-062026-09-04
Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
Fucoxanthin, Placebo - Metabolic Syndrome
Phase 2CompletedUniversity of Guadalajara282019-09-302024-11-21
Oral Dietary Fucoxanthin Rich Supplement for Liver Health
Placebo, FucoVital - Non Alcoholic Fatty Liver
Not applicableUnknownAlgatechnologies Ltd.302018-09-102018-08-14

Conditions studied

Albuminuria (1)  ·  Diabetic Nephropathies (1)  ·  Insulin Resistance (1)  ·  Metabolic Syndrome (1)  ·  Non-alcoholic Fatty Liver Disease (1)

Sponsors

Algatechnologies Ltd. (1)  ·  Taipei Medical University WanFang Hospital (1)  ·  University of Guadalajara (1)

Countries

Mexico (1)  ·  Taiwan (1)

Top investigators

Haim Shirin, Prof. (1)  ·  Manuel Gonzalez Ortiz, MD MSc Phd (1)

Results publications

PMID 33993853, PMID 37405785